Daimiel, Lidia http://orcid.org/0000-0001-9898-6629
Martínez-González, Miguel A.
Corella, Dolores http://orcid.org/0000-0002-2366-4104
Salas-Salvadó, Jordi http://orcid.org/0000-0003-2700-7459
Schröder, Helmut
Vioque, Jesús
Romaguera, Dora
Martínez, J. Alfredo
Wärnberg, Julia
Lopez-Miranda, Jose
Estruch, Ramón http://orcid.org/0000-0003-1260-4445
Cano-Ibáñez, Naomi
Alonso-Gómez, Angel
Tur, Josep A.
Tinahones, Francisco J.
Serra-Majem, Lluis
Micó-Pérez, Rafael M.
Lapetra, José
Galdón, Alba
Pintó, Xavier
Vidal, Josep
Micó, Victor
Colmenarejo, Gonzalo http://orcid.org/0000-0002-8249-4547
Gaforio, José J. http://orcid.org/0000-0003-2996-9301
Matía, Pilar
Ros, Emilio
Buil-Cosiales, Pilar
Vázquez-Ruiz, Zenaida
Sorlí, José V. http://orcid.org/0000-0002-0130-2006
Graniel, Indira Paz http://orcid.org/0000-0002-3204-6877
Cuenca-Royo, Aida
Gisbert-Sellés, Cristina
Galmes-Panades, Aina M.
Zulet, M. Angeles
García-Ríos, Antonio
Díaz-López, Andrés
de la Torre, Rafael http://orcid.org/0000-0002-6765-1866
Galilea-Zabalza, Iñigo
Ordovás, José M. http://orcid.org/0000-0002-7581-5680
Article History
Received: 9 July 2019
Accepted: 27 January 2020
First Online: 26 February 2020
Competing interests
: Jordi Salas-Salvadó. reports serving on the board of and receiving grant support through his institution from International Nut and Dried Fruit Council; receiving personal consulting fees from Danone, Font Vella Lanjaron, Nuts for Life, and Eroski; and receiving grant support through his institution from Nut and Dried Fruit Foundation and Eroski. Emilio Ros reports grants, non-financial support, and other fees from California Walnut Commission and Alexion; personal fees and non-financial support from Merck, Sharp & Dohme; personal fees, non-financial support and other fees from Aegerion, and Ferrer International; grants and personal fees from Sanofi Aventis; grants from Amgen and Pfizer and; personal fees from Akcea, outside of the submitted work. Xavier Pintó reports serving on the board of and receiving consulting personal fees from Sanofi Aventis, Amgen, and Abbott Laboratories; receiving personal lecture fees from Esteve, Lacer, and Rubio laboratories. Victor Micó reports grants from Fundación Cerveza y Salud. All other authors declare no competing interests.